Current Psychiatry Reports
GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation
By Fabrizio Schifano, Maria Antonietta De Luca, Stefania Bonaccorso, Show 6 more authorsAmira Guirguis
Systematic reviewInterventions
Declared no competing interests
- GLP-1 receptor agonists
- GIP/GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Anxiety
- Depression
- Humans
The paper
University of Hertfordshire; Swansea University
Current Psychiatry Reports, 21 Aug 2026
